Participants were recruited through local newspapers, online media, and flyers at the Department of Endocrinology, Hvidovre Hospital and the Department of Biomedical Sciences, University of Copenhagen
The glucagon receptor antagonists (GRA) L-168049 and REMD2.59 were from Tocris Bioscience (Bristol, UK) and REMD Biotherapeutics Inc (Camarillo, CA, USA), respectively
Birkenfeld is also involved, has carried out an international randomized, double-blind study to compare semaglutide in tablet form with sitagliptin , the diabetes medication most commonly prescribed as second-line therapy
Since 2014, they have become one of the brand's first bestsellers, significantly contributing to its international development and earning global recognition